BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests if kids with brain tumors can stop treatment safely
Disease control Recruiting nowThis study is for children and young adults (1-25 years old) with a specific type of slow-growing brain tumor that has a BRAF V600 gene mutation. The goal is to see if patients who have taken the drugs dabrafenib and trametinib successfully for 12-24 months can either stop the dr…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New pill targets 'Undruggable' cancer mutations in major trial
Disease control Recruiting nowThis study is testing a new oral drug, S241656, alone and in combination with other cancer therapies. It aims to find a safe and effective dose for adults with advanced cancers, including lung, pancreatic, and colorectal cancers, that have specific genetic mutations like KRAS or …
Matched conditions: BRAF V600 MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Doctors test tailored melanoma treatment based on surgery response
Disease control Recruiting nowThis study tests whether treatment decisions for advanced melanoma can be personalized based on how well tumors respond to drug therapy before surgery. Patients with specific genetic mutations receive targeted drugs before surgery, then get different follow-up treatments dependin…
Matched conditions: BRAF V600 MUTATION
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC